Phase 3 Hypertensive Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
ObesityOverweightHypertensive
Innovent Biologics (Suzhou) Co. Ltd.336 enrolled1 locationNCT07469800
Recruiting
Phase 3
Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Assistance Publique - Hôpitaux de Paris66 enrolled1 locationNCT05726916
Not Yet Recruiting
Phase 3
Mechanism of cardiovascular benefits of omega-3 fatty acids in hypertensive and normotensive subjects
Hypertensive men and women
University of the Sunshine Coast140 enrolled1 locationACTRN12610000713099